Lilly Pipeline Has Six NMEs That Could Launch By 2011, CEO Taurel Says
Executive Summary
Lilly plans to launch an average of two products per year beginning in 2011 and three per year beginning in 2014, CEO Sidney Taurel told analysts Dec. 6 in New York
You may also be interested in...
Lilly’s Zyprexa Protection Strategy: Stress Efficacy, Institutional Market
Lilly will protect Zyprexa's market share from generic competition by emphasizing the atypical antipsychotic's efficacy and by focusing on the institutional, urgent-need patient market, President and incoming CEO John Lechleiter said during the company's Jan. 29 sales and earnings call
Lilly’s Zyprexa Protection Strategy: Stress Efficacy, Institutional Market
Lilly will protect Zyprexa's market share from generic competition by emphasizing the atypical antipsychotic's efficacy and by focusing on the institutional, urgent-need patient market, President and incoming CEO John Lechleiter said during the company's Jan. 29 sales and earnings call
Lilly Leadership Falls To Lechleiter In ’08 As Taurel Resigns As CEO
The appointment of Lilly President and Chief Operating Officer John Lechleiter to CEO should be a smooth transition in early 2008 when longtime chief exec Sidney Taurel retires